✦ LIBER ✦

Correlation of Patient-Related Factors and Dose-Volume Histogram Parameters with the Onset of Radiation Pneumonitis in Patients with Small Cell Lung Cancer

✍ Scribed by Falk Roeder; Jochen Friedrich; Carmen Timke; Jutta Kappes; Peter Huber; Robert Krempien; Juergen Debus; Marc Bischof

Publisher: Springer
Year: 2010
Tongue: German
Weight: 322 KB
Volume: 186
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-010-2018-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of related factors associated w

✍ Jun Dang; Guang Li; Xiaobe Lu; Lei Yao; Shuo Zhang; Zhan Yu 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 362 KB

Comparisons of Dose-Volume Histograms fo

Comparisons of Dose-Volume Histograms for Proton-Beam versus 3-D Conformal X-Ray Therapy in Patients with Stage I Non-Small Cell Lung Cancer

✍ Changlu Wang; Hidetsugu Nakayama; Shinji Sugahara; Takeji Sakae; Koichi Tokuuye 📂 Article 📅 2009 🏛 Springer 🌐 German ⚖ 278 KB

A dose-finding and pharmacokinetic study

A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer

✍ Noboru Yamamoto; Tomohide Tamura; Takayasu Kurata; Nobuyuki Yamamoto; Ikuo Sekin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

Radiation dosimetry and biodistribution

Radiation dosimetry and biodistribution of99mTc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer

✍ Naomi R. Schechter; William D. Erwin; David J. Yang; E. Edmund Kim; Reginald F. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 245 KB

Canadian multicentre randomized trial co

Canadian multicentre randomized trial comparing two dose levels of thoracic radiation given in combination with chemotherapy to patients with limited small cell lung cancer

✍ P. Coy; W.K. Evans; R. Feld; I. Hodson; A.S. MacDonald; D. Osoba; D.G. Payne; J. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Dose escalation study of carboplatin wit

Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan

✍ Nobuyuki Katakami; Minoru Takada; Shunichi Negoro; Katsuyasu Ota; Jiro Fujita; K 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

## BACKGROUND. We performed a Phase 1-11 trial to determine the maximum tolerated dose of carboplatin (CBDCA) with a fixed dose of VP-16 and granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC) patients. ## METHODS. Treatment consisted of a starting dose of CBDCA, 400